肺腺癌肿瘤标志物研究现状

Research status of tumor markers in lung adenocarcinoma

肺腺癌占非小细胞肺癌（NSCLC）的70％左右。且现在检测到的比率更高，如能早期诊断、早期治疗，则能大大改善肺腺癌患者的愈后及提高患者的生存率；诊断肺癌的检查如气管镜取病理、胸壁穿刺取病理等，存在有创操作或标本不易获取等不足，但肿瘤标志物较容易获取，且近年一系列研究表明，肿瘤标志物联合检测对肺腺癌的早期发现及诊断、愈后预测、肿瘤复发等都有极大的价值。

Lung adenocarcinoma accounted for about 70% of non-small cell lung cancer, and now a higher risk of detected. Early diagnosis and early treatment can significantly improve lung adenocarcinoma patients after operation and improve the survival rate of patients. Bronehoseope clinical diagnosis of lung cancer and chest wall puncture in pathology has problem in that it is an operation and specimen is not easy to get, compared to tumor markers that are easy to obtain. A series of studies in recent years have shown that the joint detection of tumor markers has important value in early detection and diagnosis, prognosis as- sessment, and tumor recurrence of lung adenocarcinoma.